Enabling a life for lactose intolerant individuals without dietary limitations, symptoms, and uncertainty by the utilization of gene therapy.

Milky Way Biotech's mission directly addresses SDG 3 by working to improve the health and well-being of individuals who suffer from lactose intolerance. The development of an effective therapy can enhance the quality of life for affected individuals.

We are a competent team
with a big dream

Our Milky Way Biotech journey began with a visionary idea conceived by Mario and Patrik, who forged their friendship while studying at Professionshøjskolen Absalon. Inspired to embark on a new adventure, they co-founded Milky Way Biotech, a testament to their shared ambition. Together, they assembled a diverse and highly skilled team comprising individuals from various nationalities and educational backgrounds. These remarkable individuals have laid the solid groundwork for our ever-evolving startup.

Patrik Szoboszlai

Patrik Szoboszlai

Chief Executive Officer

Angeliki Panetsou

Angeliki Panetsou

Molecular Biologist in Charge of Vector Delivery

Mario Alzamora

Mario Alzamora

Lead Researcher in Charge of Pre-clinical Studies

Penille Jensen

Penille Jensen

Pre-clinical Responsible

Divya Dasagrandhi

Divya Dasagrandhi

Pre-clinical Researcher

Ioanna Chini

Ioanna Chini

Molecular Biologist

André Gil Castro

André Gil Castro

Chief Information Officer

industry leading mentors

Kamilla Rolsted

Entrepreneur and business developer, currently working as the Chief Business Officer of Pephexia Therapeutics ApS. 10+ years of experience in the field of health care innovation and business development. Contributing to the development of the “Milky Way business strategy” along regular mentoring sessions.

Kamilla Rolsted

Petteri Heljo

Head of Oral Drug Product Research with 15+ years in pharma, Petteri leads the Oral Drug Product Research at Novo Nordisk. His experience in leading oral biologic formulation research will be pivotal in ensuring our gene therapy navigates safely through the gastric acids and into the gut, where it can interact with the target cells.

Petteri Heljo

This is how we will solve lactose intolerance

We are a strong team brought together by a shared vision and a wealth of expertise. Comprising highly skilled researchers from the esteemed Technical University of Denmark, we are united to eliminate lactose intolerance by developing a groundbreaking single-pill genetic therapy.

Our strength lies in our collective multidisciplinary expertise, and our dedication to making lactose intolerance a relic of the past. Together, we form a team capable of tackling complex challenges and achieving meaningful progress in the world of healthcare.

Diverse Expertise

Our team brings together a diverse range of expertise, from genetics and biotechnology to data science and clinical research. This diversity allows us to approach the problem from multiple angles and develop innovative solutions.

Collaborative Spirit

Collaboration is at the heart of our approach. We believe that the collective intelligence of our team, combined with a shared commitment to our mission, is the key to finding effective solutions for lactose intolerance.

Cutting-Edge Research

We are committed to staying at the forefront of scientific research and technology. This dedication enables us to explore and develop cutting-edge genetic therapy methods that hold promise for eradicating lactose intolerance.

Ethical Practices

Ethical values are embedded in our work. We maintain transparency in our research, trials, and operations, ensuring that ethical standards guide every decision we make.

Long-Term Commitment

Our motives go beyond short-term gains. We are committed to the long-term success of our mission, which includes continuous improvement, adaptability, and a focus on sustainable outcomes.

Ambition to Make a Difference

We are driven by a shared ambition to make a significant impact on the lives of those affected by lactose intolerance. Our dedication to this cause motivates us to explore groundbreaking methods and push the boundaries of genetic therapy.

Patient-Centered Approach

Our team values the well-being of patients above all else. We prioritize patient needs and experiences throughout our research and development process, ensuring that our solutions are practical and beneficial.

Global Perspective

With team members from diverse nationalities, we have a global perspective on the problem. This allows us to consider different cultural and regional factors, ensuring our solutions are universally applicable.

Our commitment in eradicating lactose intolerance is fueled by a dedicated team of experts who bring diverse skills. We invite you to join us in this journey, whether you have questions, ideas, or simply wish to connect. Your passion and skills can be the driving force behind a brighter and healthier future.
Partner with us
Be part of the future
Join the team
Let's work together